VAERS Datenanalyse und Statistik
Zurueck zur Suche

Reporte zur Charge 4ZN3H

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

1Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
PA 1

VAERS 2671001

GLAXOSMITHKLINE BIOLOGICALS · HEP B (ENGERIX-B) · Charge 4ZN3H

gering
Staat
PA
Alter
56,0
Geschlecht
M
Eingang
14.08.2023
Impfdatum
25.07.2023
Beginn
25.07.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age Underdose

Symptomtext

adult patient was given a pediatric dose of Engerix-B.; adult patient was given a pediatric dose of Engerix-B.; This non-serious case was reported by a nurse via call center representative and described the occurrence of underdose in a 56-year-old male patient who received HBV (Engerix B 10 mcg) (batch number 4ZN3H, expiry date 28-MAR-2025) for prophylaxis. On 25-JUL-2023, the patient received Engerix B 10 mcg. On 25-JUL-2023, an unknown time after receiving Engerix B 10 mcg, the patient experienced underdose (Verbatim: adult patient was given a pediatric dose of Engerix-B.) and adult use of a child product (Verbatim: adult patient was given a pediatric dose of Engerix-B.). The outcome of the underdose and adult use of a child product were unknown. Additional Information: Receipt date: 10-AUG-2023 The nurse reported an adult patient was given a pediatric dose of Engerix-B, which led to underdose and adult use of a child product. The vaccine administration facility is the same as primary reporter. The reporter consented to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-